Scynexis Inc (SCYX): Next-Year EPS Estimate 40.16%
As of 2026-06-11, Scynexis Inc (SCYX) has a next-year EPS growth estimate of 40.16%.
On 2026-05-13, analyst consensus for SCYX's next-year EPS growth shifted from 41.96% to 40.16% — a negative change of 1.80 percentage points. The revised estimate has been sustained across 22 subsequent trading sessions. Current-year growth is projected at -139.22%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 40.16%
- EPS growth this year
- -139.22%
- EPS next quarter (est)
- -$0.51
- Last price
- $4.24
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 40.16% | -139.22% | -$0.51 | $4.24 |
| 2026-06-10 | 40.16% | -139.22% | -$0.51 | $4.15 |
| 2026-06-09 | 40.16% | -139.22% | -$0.51 | $4.36 |
| 2026-06-08 | 40.16% | -139.22% | -$0.51 | $4.45 |
| 2026-06-07 | 40.16% | -139.22% | -$0.51 | $4.71 |
| 2026-06-04 | 40.16% | -139.22% | -$0.51 | $4.88 |
| 2026-06-03 | 40.16% | -139.22% | -$0.51 | $4.67 |
| 2026-06-02 | 40.16% | -139.22% | -$0.51 | $5.10 |
| 2026-06-01 | 40.16% | -139.22% | -$0.51 | $5.33 |
| 2026-05-31 | 40.16% | -139.22% | -$0.06 | $0.70 |
| 2026-05-28 | 40.16% | -139.22% | -$0.06 | $0.74 |
| 2026-05-27 | 40.16% | -139.22% | -$0.06 | $0.70 |
| 2026-05-26 | 40.16% | -139.22% | -$0.06 | $0.68 |
| 2026-05-25 | 40.16% | -139.22% | -$0.06 | $0.73 |
| 2026-05-24 | 40.16% | -139.22% | -$0.06 | $0.73 |
| 2026-05-21 | 40.16% | -139.22% | -$0.06 | $0.71 |
| 2026-05-20 | 40.16% | -139.22% | -$0.06 | $0.67 |
| 2026-05-19 | 40.16% | -139.22% | -$0.06 | $0.66 |
| 2026-05-18 | 40.16% | -139.22% | -$0.06 | $0.69 |
| 2026-05-17 | 40.16% | -139.22% | -$0.06 | $0.74 |
| 2026-05-14 | 40.16% | -139.22% | -$0.06 | $0.77 |
| 2026-05-13 | 40.16% | -139.22% | -$0.06 | $0.77 |
| 2026-05-12 | 41.96% | -119.61% | -$0.09 | $0.78 |
| 2026-05-11 | 41.96% | -119.61% | -$0.12 | $0.82 |
| 2026-05-10 | 41.96% | -119.61% | -$0.12 | $0.92 |
| 2026-05-07 | 41.96% | -119.61% | -$0.12 | $0.96 |
| 2026-05-06 | 41.96% | -119.61% | -$0.12 | $0.98 |
| 2026-05-05 | 41.96% | -119.61% | -$0.12 | $0.94 |
| 2026-05-04 | 41.96% | -119.61% | -$0.12 | $0.98 |
| 2026-05-03 | 41.96% | -119.61% | -$0.12 | $0.99 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Scynexis Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Scynexis Inc (SCYX) has a next-year EPS growth estimate of 40.16%, based on analyst consensus.
When was the latest EPS estimate revision for SCYX?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 41.96% to 40.16%.
What sector and industry does Scynexis Inc belong to?▾
Scynexis Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SCYX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Scynexis Inc (SCYX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports